Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia (Q40272415)

19 September 2017

Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia (English)

1 reference

19 September 2017

1 reference

Streptococcus pneumoniae

1 reference

6

P D Siersema

1 reference

19 September 2017

C P C de Jager

1

1 reference

19 September 2017

P C Wever

2

1 reference

19 September 2017

E F A Gemen

3

1 reference

19 September 2017

M G H van Oijen

4

1 reference

19 September 2017

A B van Gageldonk-Lafeber

5

1 reference

19 September 2017

G C M Kusters

7

1 reference

19 September 2017

R J F Laheij

8

1 reference

19 September 2017

language of work or name

English

0 references

publication date

3 October 2012

1 reference

Alimentary Pharmacology & Therapeutics

19 September 2017

1 reference

19 September 2017

36

1 reference

19 September 2017

10

1 reference

19 September 2017

941-949

1 reference

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

19 September 2017

1 reference

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs

21 January 2018

1 reference

Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia

21 January 2018

1 reference

Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials

21 January 2018

1 reference

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

21 January 2018

1 reference

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

21 January 2018

1 reference

Proton pump inhibitor use and enteric infections

21 January 2018

1 reference

Adverse effects of proton pump inhibitor drugs: clues and conclusions

21 January 2018

1 reference

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study

21 January 2018

1 reference

Review article: proton pump inhibitors and bacterial overgrowth

21 January 2018

1 reference

Occurrence and significance of gastric colonization during acid-inhibitory therapy

21 January 2018

1 reference

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung

21 January 2018

1 reference

Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials

21 January 2018

1 reference

Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial

21 January 2018

1 reference

Microbial evaluation of proton-pump inhibitors and the risk of pneumonia.

21 January 2018

1 reference

Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.

21 January 2018

1 reference

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

21 January 2018

1 reference

Gastric acid‐suppressive therapy and community‐acquired respiratory infections

21 January 2018

1 reference

Acid-suppressive medication use and the risk for hospital-acquired pneumonia

21 January 2018

1 reference

Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity

21 January 2018

1 reference

Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands

21 January 2018

1 reference

Persistence and adherence to proton pump inhibitors in daily clinical practice

21 January 2018

1 reference

Epidemiology of community-acquired pneumonia in adults: a population-based study

21 January 2018

1 reference

Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community

21 January 2018

1 reference

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity

21 January 2018

1 reference

Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome- a systematic review

21 January 2018

1 reference

Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial

21 January 2018

1 reference

Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases

21 January 2018

1 reference

Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12069

1 reference

19 September 2017

1 reference